TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.100
-0.030 (-2.65%)
At close: Nov 14, 2025, 4:00 PM EST
1.130
+0.030 (2.73%)
Pre-market: Nov 17, 2025, 8:58 AM EST
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $62.42 million as of November 17, 2025. Its market cap has decreased by -75.09% in one year.
Market Cap
62.42M
Enterprise Value
-26.41M
1-Year Change
-75.09%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $62.42M, a decrease of -82.62%. That is a compound annual growth rate of -33.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 62.42M | -63.66% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |